Introduction to Drug Development
DIA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is designated for up to 1 contact hours or .1 continuing education units (CEUs). Type of Activity: Application 0286-0000-18-046-H04-P
DIA has been reviewed and approved as a provider of project management training by the Project Management Institute (PMI®). This program offers a maximum of 1 professional development unit (PDUs).
PMI #: 2166-000219
The PMI Registered Education Provider logo is a registered mark of the Project Management Institute, Inc.
DIA has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET).
As an IACET Authorized Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer up to .1 CEUs for this program.
Release Date: May 18, 2018
Expiration Date: May 18, 2021*
*Continuing education credit is available to participants who successfully complete the eLearning program before the expiration date.
|Name||Credit Type||Max Credits||CEU|
|Introduction to Drug Development||Credit TypeACPE||Max Credits1.00||CEU0.100|
|Introduction to Drug Development||Credit TypeIACET||Max Credits1.00||CEU0.100|
|Introduction to Drug Development||Credit TypePMI||Max Credits1.00||CEU0.000|
Statement of Credit:
After a module is completed, you will be able to access the module for one year from the date of purchase.
In order to receive a statement of credit, you must complete the pre-assessment, the eLearning module, receive a passing score of 80% or better on the post-assessment, and complete the evaluation.
To review DIA’s Disclosure and Grievance Policy, visit DIAglobal.org/CE